SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is capturing significant market attention following its historic U.S. ADR debut on the Nasdaq, with investors closely watching its role as a leading provider of high-bandwidth memory for AI infrastructure. The community is actively debating the stock's valuation relative to peers like Micron, while navigating volatility driven by institutional rotation and high demand for AI-linked memory components.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently trending as bulls aggressively defend support levels, buoyed by positive analyst sentiment and high-conviction institutional inflows. The broader community remains deeply engaged in debates over AI infrastructure sustainability, supply chain bottlenecks in high-bandwidth memory, and the stock's position at the center of a long-term data center spending supercycle.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following a federal lawsuit against OpenAI alleging trade secret theft, while investors focus on its massive multi-year chip supply agreement with Broadcom to bolster AI hardware capabilities. The community is actively debating the company's legal strategy to protect its ecosystem moat versus the broader implications of its AI partnerships and stock price action.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending due to intensified buyout speculation as the pharmaceutical giant seeks to bolster its oncology pipeline ahead of the upcoming Keytruda patent cliff. Investors are actively debating potential acquisitions of clinical-stage biotech companies, with Sellas Life Sciences emerging as a focal point for discussion regarding platform-based cancer therapies.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum (OXY) is attracting significant investor interest as traders react to persistent geopolitical tensions in the Strait of Hormuz and their potential to disrupt global oil supply chains. The community is actively debating whether ongoing military actions and energy infrastructure risks justify a breakout above key resistance levels, with many focusing on the potential for institutional buying and long-term earnings upside despite short-term price volatility.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending due to intensifying buyout speculation involving Merck, as investors anticipate a major oncology acquisition ahead of a significant patent cliff. The community is actively debating the potential valuation of the company's oncology platforms and monitoring trial milestones while navigating a mix of speculative rumors and institutional accumulation.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is experiencing significant volatility driven by intense geopolitical tensions in the Middle East and fluctuating oil prices, prompting active debate among the community regarding whether the stock is a long-term value opportunity or a target for algorithmic manipulation. Investors are closely monitoring insider buying activity and shifting analyst price targets while navigating uncertainty surrounding potential conflict escalations and the stock's ability to maintain upward momentum.

Roundhill ETF Trust - Roundhill Memory ETF

Roundhill Memory ETF is facing significant volatility and investor anxiety as market participants debate whether the recent downturn is a temporary rebalancing ahead of the upcoming SK Hynix NASDAQ debut or a sign of a broader cooling in AI-driven memory demand. The community remains deeply divided, with many long-term bulls highlighting the ETF's low forward P/E multiples and essential role in the AI infrastructure stack, while bears point to excessive leverage in the South Korean market and broader profit-taking as signals of a structural trend reversal.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh persistent supply chain risks in the Strait of Hormuz against the company's aggressive production growth and strong long-term EBITDA guidance. Community sentiment remains focused on the impact of regional instability on global LNG spot markets and the potential for increased demand as infrastructure projects continue to scale.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense community engagement as investors debate its valuation amid massive short interest, with many focused on the upcoming Microsoft data center handoff as a critical execution milestone. The community remains polarized, weighing the long-term potential of the AI infrastructure pivot against concerns over share dilution and management's compensation structure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares?

Key Points41,884 shares were sold in an open-market transaction for a total of ~$183,000 on May 28, 2026...

Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices

Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices...

Precigen, Inc. (PGEN) is a Great Momentum Stock: Should You Buy?

Does Precigen, Inc. (PGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years

Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete...

Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States

Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States PR Newswire GERMANTOWN, Md., May 27, 2026 FDA grants orphan drug exclusivity for...

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference

Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire GERMANTOWN, Md., May 26, 2026...

Precigen’s Lead Cancer Therapy Is Fueling A Massive Stock Rally — Here’s What Wall Street Sees Next

Equity

Driven by Papzimeos sales, Precigen posted a revenue of $23.3 million, which came in above Wall Street’s estimates of $20.8 million, according to Fiscal.ai data.

Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates

Precigen (PGEN) delivered earnings and revenue surprises of +20.00% and +9.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Precigen Reports First Quarter 2026 Financial Results and Business Updates

Precigen Reports First Quarter 2026 Financial Results and Business Updates Precigen Reports First Quarter 2026 Financial Results and Business Updates PR Newswire GERMANTOWN, Md., May 13, 2026...

Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13

Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 PR...

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Extremely Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PGENPrecigen Inc

Fundamentals

Latest PGEN News